Microdialysis study of cefotaxime cerebral distribution in patients with acute brain injury

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 6, 2013, Pages 2738-2742

  Dahyot Fizelier, Claire ^a,b,c   Frasca, Denis ^a,b,c   Grégoire, Nicolas ^a,b   Adier, Christophe ^a,c   Mimoz, Olivier ^a,b,c   Debaene, Bertrand ^a,b,c   Couet, William ^a,b,c   Marchand, Sandrine ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ DE POITIERS   (France)

^c POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BACTERIAL STRAIN; BRAIN INJURY; BRAIN TISSUE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; LUNG INFECTION; MALE; MICRODIALYSIS; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; STEADY STATE; STREPTOCOCCUS PNEUMONIAE;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BRAIN; BRAIN INJURIES; CEFOTAXIME; EXTRACELLULAR FLUID; FEMALE; HUMANS; LUNG DISEASES; MALE; MICROBIAL SENSITIVITY TESTS; MICRODIALYSIS; MIDDLE AGED;

EID: 84877859062     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02570-12     Document Type: Article

References (36)

1. Chaudhuri A, Martinez-Martin P, Kennedy PG, Andrew Seaton R, Portegies P, Bojar M, Steiner I. 2008. EFNS guideline on the management of community-acquired bacterial meningitis: Report of an EFNS task force on acute bacterial meningitis in older children and adults. Eur. J. Neurol. 15:649-659.
2. van de Beek D, Drake JM, Tunkel AR. Nosocomial bacterial meningitis. N. Engl. J. Med. 362:146-154.
3. Gerber J, Nau R. 2010. Mechanisms of injury in bacterial meningitis. Curr. Opin. Neurol. 23:312-318.
4. Orihuela CJ, Mahdavi J, Thornton J, Mann B, Wooldridge KG, Abouseada N, Oldfield NJ, Self T, Ala'Aldeen DA, Tuomanen EI. 2009. Laminin receptor initiates bacterial contact with the blood brain barrier in experimental meningitis models. J. Clin. Invest. 119:1638-1646.
5. Nau R, Prange HW, Muth P, Mahr G, Menck S, Kolenda H, Sorgel F. 1993. Passage of cefotaxime and ceftriaxone into cerebrospinal fluid of patients with uninflamed meninges. Antimicrob. Agents Chemother. 37: 1518-1524.
6. Humbert G, Leroy A, Nair SR, Cherubin CE. 1984. Concentrations of cefotaxime and the desacetyl metabolite in serum and CSF of patients with meningitis. J. Antimicrob. Chemother. 13:487-494.
7. Trang JM, Jacobs RF, Kearns GL, Brown AL, Wells TG, Underwood FL, Kluza RB. 1985. Cefotaxime and desacetylcefotaxime pharmacokinetics in infants and children with meningitis. Antimicrob. Agents Chemother. 28:791-795.
8. Goldwater PN. 2005. Cefotaxime and ceftriaxone cerebrospinal fluid levels during treatment of bacterial meningitis in children. Int. J. Antimicrob. Agents 26:408-411.
9. Westerhout J, Danhof M, De Lange EC. 2011. Preclinical prediction of human brain target site concentrations: Considerations in extrapolating to the clinical setting. J. Pharm. Sci. 100:3577-3593.
10. Blakeley JO, Olson J, Grossman SA, He X, Weingart J, Supko JG. 2009. Effect of blood brain barrier permeability in recurrent high grade gliomas on the intratumoral pharmacokinetics of methotrexate: A microdialysis study. J. Neurooncol. 91:51-58.
11. Hlatky R, Valadka AB, Goodman JC, Robertson CS. 2004. Evolution of brain tissue injury after evacuation of acute traumatic subdural hematomas. Neurosurgery 55:1318-1323.
12. Dahyot-Fizelier C, Timofeev I, Marchand S, Hutchinson P, Debaene B, Menon D, Mimoz O, Gupta A, Couet W. 2010. Brain microdialysis study of meropenem in two patients with acute brain injury. Antimicrob. Agents Chemother. 54:3502-3504.
13. Dahyot C, Marchand S, Bodin M, Debeane B, Mimoz O, Couet W. 2008. Application of basic pharmacokinetic concepts to analysis of microdialysis data: Illustration with imipenem muscle distribution. Clin. Pharmacokinet. 47:181-189.
14. Karjagin J, Lefeuvre S, Oselin K, Kipper K, Marchand S, Tikkerberi A, Starkopf J, Couet W, Sawchuk RJ. 2008. Pharmacokinetics of meropenem determined by microdialysis in the peritoneal fluid of patients with severe peritonitis associated with septic shock. Clin. Pharmacol. Ther. 83:452-459.
15. Hammarlund-Udenaes M, Paalzow LK, de Lange EC. 1997. Drug equilibration across the blood-brain barrier-pharmacokinetic considerations based on the microdialysis method. Pharm. Res. 14:128-134.
16. EUCAST. 2012. Breakpoint tables and interpretation of MICs and zone diameters. Version 2.0. http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST- files/Disk-test-documents/EUCAST-breakpoints-v-2.0-120 101.pdf.
17. Esmieu F, Guibert J, Rosenkilde HC, Ho I, Le Go A. 1980. Pharmacokinetics of cefotaxime in normal human volunteers. J. Antimicrob. Chemother. 6(Suppl A):83-92.
18. Bouw MR, Hammarlund-Udenaes M. 1998. Methodological aspects of the use of a calibrator in in vivo microdialysis-further development of the retrodialysis method. Pharm. Res. 15:1673-1679.
19. Caricato A, Pennisi M, Mancino A, Vigna G, Sandroni C, Arcangeli A, Antonelli M. 2006. Levels of vancomycin in the cerebral interstitial fluid after severe head injury. Intens. Care Med. 32:325-328.
20. Mindermann T, Zimmerli W, Gratzl O. 1998. Rifampin concentrations in various compartments of the human brain: A novel method for determining drug levels in the cerebral extracellular space. Antimicrob. Agents Chemother. 42:2626-2629.
21. Brunner M, Reinprecht A, Illievich U, Spiss CK, Dittrich P, van Houte M, Muller M. 2002. Penetration of fosfomycin into the parenchyma of human brain: A case study in three patients. Br. J. Clin. Pharmacol. 54: 548-550.
22. Poeppl W, Zeitlinger M, Donath O, Wurm G, Muller M, Botha F, Illievich UM, Burgmann H. 2012. Penetration of doripenem in human brain: An observational microdialysis study in patients with acute brain injury. Int. J. Antimicrob. Agents 39:343-345.
23. Nau R, Sorgel F, Eiffert H. 2010. Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections. Clin. Microbiol. Rev. 23:858-883.
24. Akanuma S-I, Uchida Y, Ohtsuki S, Kamiie J-i, Tachikawa M, Terasaki T, Hosoya K-I. 2011. Molecular-weight-dependent, anionic-substratepreferential transport of Î2-lactam antibiotics via multidrug resistanceassociated protein 4. Drug Metab. Pharmacokinetics 26:602-611.
25. Spector R. 2010. Nature and consequences of mammalian brain and CSF efflux transporters: Four decades of progress. J. Neurochem. 112:13-23.
26. Shen H, Ocheltree SM, Hu Y, Keep RF, Smith DE. 2007. Impact of genetic knockout of PEPT2 on cefadroxil pharmacokinetics, renal tubular reabsorption, and brain penetration in mice. Drug Metab. Dispos. 35: 1209-1216.
27. Kusuhara H, Sugiyama Y. 2005. Active efflux across the blood-brain barrier: Role of the solute carrier family. NeuroRx 2:73-85.
28. Loscher W, Potschka H. 2005. Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases. Prog. Neurobiol. 76:22-76.
29. Shen H, Keep RF, Hu Y, Smith DE. 2005. PEPT2 (Slc15a2)-mediated unidirectional transport of cefadroxil from cerebrospinal fluid into choroid plexus. J. Pharmacol. Exp. Ther. 315:1101-1108.
30. Shen H, Smith DE, Keep RF, Brosius FC, III. 2004. Immunolocalization of the proton-coupled oligopeptide transporter PEPT2 in developing rat brain. Mol. Pharm. 1:248-256.
31. Société de pathologie infectieuse de langue française. 2009. 17th consensus conference. Consensus conference on bacterial meningitis. Short text. Med. Malad. Infect. 39:175-186.
32. Frasca D, Dahyot-Fizelier C, Couet W, Debaene B, Mimoz O, Marchand S. 2012. Brain microdialysis distribution study of cefotaxime in a patient with traumatic brain injury. Br. J. Anaesth. 109:830-831.
33. Andes DR, Craig WA. 1999. Pharmacokinetics and pharmacodynamics of antibiotics in meningitis. Infect. Dis. Clin. North Am. 13:595-618.
34. Lutsar I, Friedland IR. 2000. Pharmacokinetics and pharmacodynamics of cephalosporins in cerebrospinal fluid. Clin. Pharmacokinet. 39:335-343.
35. Turnidge JD. 1998. The pharmacodynamics of beta-lactams. Clin. Infect. Dis. 27:10-22.
36. Rodriguez-Cerrato V, McCoig CC, Michelow IC, Ghaffar F, Jafri HS, Hardy RD, Patel C, Olsen K, McCracken GH, Jr. 2001. Pharmacodynamics and bactericidal activity of moxifloxacin in experimental Escherichia coli meningitis. Antimicrob. Agents Chemother. 45:3092-3097.